Moderna Inc. buy UBS Group AG
Start price
08.01.25
/
50%
€43.07
Target price
08.01.26
€93.16
Performance (%)
-31.79%
End price
09.01.26
€29.38
Summary
This prediction ended on 09.01.26 with a price of €29.38. Massive losses of -31.79% were the result for the BUY prediction by UBS_Group_AG. UBS_Group_AG has a follow-up prediction for Moderna Inc. where he still thinks Moderna Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moderna Inc. | 3.339% | 3.339% | 110.828% |
| iShares Core DAX® | 0,41 % | 8,82 % | 12,26 % |
| iShares Nasdaq 100 | 3,68 % | 10,82 % | 44,02 % |
| iShares Nikkei 225® | 2,70 % | 15,25 % | 48,04 % |
| iShares S&P 500 | 2,44 % | 7,93 % | 33,00 % |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at UBS Group AG from $108.00 to $96.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten